1. Home
  2. Analysis
  3. Micafungin
  4. Herpes-zoster

Micafungin and Herpes zoster - a phase IV clinical study of FDA data

Summary:

Herpes zoster is reported as a side effect among people who take Micafungin (micafungin sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lenalidomide, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Herpes zoster when taking Micafungin. It is created by eHealthMe based on reports of 6,557 people who have side effects when taking Micafungin from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Herpes zoster?

Herpes zoster is found to be associated with 1,823 drugs and 2,166 conditions by eHealthMe. Check the latest studies of Herpes zoster.

On Jul, 13, 2026

6,557 people reported to have side effects when taking Micafungin.
Among them, 75 people (1.14%) have Herpes zoster.

Could Micafungin cause Herpes zoster?

Among these 75 people:

How long have people been on Micafungin when they have Herpes zoster? *

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Herpes zoster when taking Micafungin? *

  • female: 68.49 %
  • male: 31.51 %

What is the age of people who have Herpes zoster when taking Micafungin? *

  • 0-1: 0.0 %
  • 2-9: 5.56 %
  • 10-19: 15.28 %
  • 20-29: 1.39 %
  • 30-39: 11.11 %
  • 40-49: 6.94 %
  • 50-59: 51.39 %
  • 60+: 8.33 %

What are other drugs people take besides Micafungin? *

  1. Thalidomide: 32 people, 42.67%
  2. Lenalidomide: 32 people, 42.67%
  3. Methylprednisolone Sodium Succinate: 21 people, 28.00%
  4. Bendamustine: 17 people, 22.67%
  5. Bortezomib: 17 people, 22.67%
  6. Methotrexate: 17 people, 22.67%
  7. Fluconazole: 16 people, 21.33%
  8. Cyclophosphamide: 14 people, 18.67%
  9. Tacrolimus: 13 people, 17.33%
  10. Fludarabine Phosphate: 12 people, 16.00%

What are other side effects people have besides Herpes zoster? *

  1. Pain: 36 people, 48.00%
  2. Oral Disorder (mouth disease): 35 people, 46.67%
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 34 people, 45.33%
  4. Pneumonia Fungal: 33 people, 44.00%
  5. Gastrointestinal Fungal Infection: 32 people, 42.67%
  6. Oral Fungal Infection: 32 people, 42.67%
  7. Sinusitis (inflammation of sinus): 32 people, 42.67%
  8. Sinus Polyp (abnormal tissue growths that grow inside the nasal passages and sinuses): 32 people, 42.67%
  9. Enterococcal Sepsis: 32 people, 42.67%
  10. Mucosal Erosion (peeling off of mucous membrane): 32 people, 42.67%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 33 people, 44.00%
  2. Bone Marrow Conditioning Regimen: 26 people, 34.67%
  3. Constipation: 8 people, 10.67%
  4. Diarrhea: 7 people, 9.33%
  5. Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 8.00%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 6.67%
  7. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 5 people, 6.67%
  8. Subclavian Vein Thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein): 5 people, 6.67%
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 5.33%
  10. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and have Herpes zoster?

- Check whether Herpes zoster is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micafungin:

Herpes zoster treatments and more:

How severe was Herpes zoster and when was it recovered:

Expand to all the drugs that have ingredients of micafungin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micafungin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Herpes zoster:

Browse all the conditions that are associated with Herpes zoster:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on micafungin sodium (the active ingredients of Micafungin) and Micafungin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.